Top Markets
Coin of the day
Idogen AB (publ) Idogen AB (publ)

Idogen AB (publ)

IDOGEN
Rangering i aksjer #37811
Idogen AB (publ) is a Swedish biotechnology company specializing in the... Idogen AB (publ) is a Swedish biotechnology company specializing in the development of tolerogenic cell therapies. These innovative treatments are engineered to prevent a patient's immune system from attacking crucial elements, including biological agents, transplanted organs, and the body's own cells or tissues. The company's most advanced product in development is IDO 8, designed for individuals with severe haemophilia A who have developed neutralizing antibodies against their vital coagulation factor VIII treatment. Idogen is also developing IDO T, a tolerogenic cell therapy intended to prevent organ transplant rejection, primarily for kidney transplants, and IDO AID, aimed at treating autoimmune diseases. Established in 2008, the company is headquartered in Lund, Sweden.
Aksjekurs
$0.01345907
Sist synkronisert: 2024-07-12
Markedsverdi
$1.43M
Endring (1 dag)
22.16%
Endring (1 år)
0.00%
Land
SE
Handel Idogen AB (publ) (IDOGEN)

Kategori

P/B-forhold for Idogen AB (publ) (IDOGEN)
P/B-forhold per 2026 TTM: 0
Ifølge Idogen AB (publ) sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for Idogen AB (publ) fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
6.3419 -
US
6.2413 -
NL
- -
CH
- -
KR
3.4612 -
BE